Krish Ramadurai

Partner at AIX Ventures

View Live Interactive Profile →

Biography

Krish Ramadurai is a Partner at AIX Ventures, working from the firm's HQ team. He is also a Partner at Harmonix Fund, where he specializes in life sciences, healthcare and deep technology, and he has sourced or led diligence on more than 30 early-stage investments including Insilico Medicine, Bit.Bio, Caresyntax and Rad AI. He has held board positions at Sorcero, xCures and Precipoint, and advises Nucleate and the National Venture Capital Association. Earlier he was a researcher at Harvard's Belfer Center and at MIT, and trained under Nobel Laureate Michael Kremer on USAID's Development Innovation Ventures Fund. He has guest lectured in Tissue and Biochemical Engineering at Harvard and authored three books on applied engineering and medicine. He holds a DPhil and master's from Oxford, an MBA from Washington University in St. Louis, a master's in Biology from Harvard and a bachelor's from the University of Illinois at Urbana-Champaign.

Education

• DPhil, Engineering Science & Nanomedicine, University of Oxford
• Masters, Engineering Science & Nanomedicine, University of Oxford
• MBA, Washington University in St. Louis
• Masters, Biology, Harvard University
• B.S., Integrative Biology & Economics (Chemistry minor), University of Illinois at Urbana-Champaign

Previous Experience

• Partner, Harmonix Fund
• Researcher, Harvard Belfer Center
• Researcher, MIT
• Guest lecturer in Tissue & Biochemical Engineering, Harvard University
• Advisor, Nucleate
• Advisor, National Venture Capital Association

Notable Investments

Board Seats

• Sorcero
• xCures
• Precipoint

Sources & References